Clinical Trial Update: Safety and Efficacy of 3 Different Doses of Long Acting Factor VII in Haemophilia A or B Patients With Inhibitors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of three dosing regimens of a long-acting factor VII in haemophilia A or B patients with inhibitors has been comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Bleeding Disorder
• Haemophilia with Inhibitors

Drugs mentioned

• Long Acting Factor VII

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Congenital Bleeding Disorder, Haemophilia A With Inhibitors | Phase 2 | Status: COMPLETED